Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals

Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals

Three unique subtypes of N-hydroxyamides and N-hydroxycarbamates containing both the vanilloid moiety (4-hydroxy-3-methoxybenzyl) and a lipophilic aliphatic moiety. Also disclosed are direct syntheses of these vanilloid fatty hydroxamates. The compounds possess inhibitory activity against the enzyme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gordon Marion, Heindel Ned D, Pillai Abhilash N, Heck Diane E, Lacey Carl Jeffrey, Laskin Jeffrey D
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Gordon Marion
Heindel Ned D
Pillai Abhilash N
Heck Diane E
Lacey Carl Jeffrey
Laskin Jeffrey D
description Three unique subtypes of N-hydroxyamides and N-hydroxycarbamates containing both the vanilloid moiety (4-hydroxy-3-methoxybenzyl) and a lipophilic aliphatic moiety. Also disclosed are direct syntheses of these vanilloid fatty hydroxamates. The compounds possess inhibitory activity against the enzymes fatty acid amide hydrolase (FAAH) and matrix metallo-proteinase 9 (MMP-9). In addition, these substances bind to the calcium channel protein TRPV1 and inhibit vesicant-induced inflammation in skin and cornea. The compounds have utility in treating topical or systemic inflammatory processes in the skin and/or eye.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9422233B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9422233B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9422233B23</originalsourceid><addsrcrecordid>eNqNyjsKAjEQgOE0FqLeYS6wTWJjq7jYWPlol2F3QgbyIhnB3N4gHsDqL75_ra5PjOx94gUsijRwbSnpjQGFKmAFcVQw00t4BozCA0frMXRPpUF2WALOX0Zft2ple2j360bBeL6fLgPlNFHN_Ywk0-N22GutjTlq88fyAQg3Ny8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals</title><source>esp@cenet</source><creator>Gordon Marion ; Heindel Ned D ; Pillai Abhilash N ; Heck Diane E ; Lacey Carl Jeffrey ; Laskin Jeffrey D</creator><creatorcontrib>Gordon Marion ; Heindel Ned D ; Pillai Abhilash N ; Heck Diane E ; Lacey Carl Jeffrey ; Laskin Jeffrey D</creatorcontrib><description>Three unique subtypes of N-hydroxyamides and N-hydroxycarbamates containing both the vanilloid moiety (4-hydroxy-3-methoxybenzyl) and a lipophilic aliphatic moiety. Also disclosed are direct syntheses of these vanilloid fatty hydroxamates. The compounds possess inhibitory activity against the enzymes fatty acid amide hydrolase (FAAH) and matrix metallo-proteinase 9 (MMP-9). In addition, these substances bind to the calcium channel protein TRPV1 and inhibit vesicant-induced inflammation in skin and cornea. The compounds have utility in treating topical or systemic inflammatory processes in the skin and/or eye.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160823&amp;DB=EPODOC&amp;CC=US&amp;NR=9422233B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160823&amp;DB=EPODOC&amp;CC=US&amp;NR=9422233B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gordon Marion</creatorcontrib><creatorcontrib>Heindel Ned D</creatorcontrib><creatorcontrib>Pillai Abhilash N</creatorcontrib><creatorcontrib>Heck Diane E</creatorcontrib><creatorcontrib>Lacey Carl Jeffrey</creatorcontrib><creatorcontrib>Laskin Jeffrey D</creatorcontrib><title>Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals</title><description>Three unique subtypes of N-hydroxyamides and N-hydroxycarbamates containing both the vanilloid moiety (4-hydroxy-3-methoxybenzyl) and a lipophilic aliphatic moiety. Also disclosed are direct syntheses of these vanilloid fatty hydroxamates. The compounds possess inhibitory activity against the enzymes fatty acid amide hydrolase (FAAH) and matrix metallo-proteinase 9 (MMP-9). In addition, these substances bind to the calcium channel protein TRPV1 and inhibit vesicant-induced inflammation in skin and cornea. The compounds have utility in treating topical or systemic inflammatory processes in the skin and/or eye.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjsKAjEQgOE0FqLeYS6wTWJjq7jYWPlol2F3QgbyIhnB3N4gHsDqL75_ra5PjOx94gUsijRwbSnpjQGFKmAFcVQw00t4BozCA0frMXRPpUF2WALOX0Zft2ple2j360bBeL6fLgPlNFHN_Ywk0-N22GutjTlq88fyAQg3Ny8</recordid><startdate>20160823</startdate><enddate>20160823</enddate><creator>Gordon Marion</creator><creator>Heindel Ned D</creator><creator>Pillai Abhilash N</creator><creator>Heck Diane E</creator><creator>Lacey Carl Jeffrey</creator><creator>Laskin Jeffrey D</creator><scope>EVB</scope></search><sort><creationdate>20160823</creationdate><title>Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals</title><author>Gordon Marion ; Heindel Ned D ; Pillai Abhilash N ; Heck Diane E ; Lacey Carl Jeffrey ; Laskin Jeffrey D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9422233B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Gordon Marion</creatorcontrib><creatorcontrib>Heindel Ned D</creatorcontrib><creatorcontrib>Pillai Abhilash N</creatorcontrib><creatorcontrib>Heck Diane E</creatorcontrib><creatorcontrib>Lacey Carl Jeffrey</creatorcontrib><creatorcontrib>Laskin Jeffrey D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gordon Marion</au><au>Heindel Ned D</au><au>Pillai Abhilash N</au><au>Heck Diane E</au><au>Lacey Carl Jeffrey</au><au>Laskin Jeffrey D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals</title><date>2016-08-23</date><risdate>2016</risdate><abstract>Three unique subtypes of N-hydroxyamides and N-hydroxycarbamates containing both the vanilloid moiety (4-hydroxy-3-methoxybenzyl) and a lipophilic aliphatic moiety. Also disclosed are direct syntheses of these vanilloid fatty hydroxamates. The compounds possess inhibitory activity against the enzymes fatty acid amide hydrolase (FAAH) and matrix metallo-proteinase 9 (MMP-9). In addition, these substances bind to the calcium channel protein TRPV1 and inhibit vesicant-induced inflammation in skin and cornea. The compounds have utility in treating topical or systemic inflammatory processes in the skin and/or eye.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9422233B2
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A32%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gordon%20Marion&rft.date=2016-08-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9422233B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true